Results 181 to 190 of about 5,087,575 (343)

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

New England Journal of Medicine, 2016
M. Fischereder, U. Schönermarck
semanticscholar   +1 more source

Virtual or In‐Person: Does It Matter? Comparing Pain, Function, Quality of Life, Self‐Efficacy, and Physical Function Outcomes of Virtual, Hybrid, and In‐Person Education and Exercise Program Participants

Arthritis Care &Research, EarlyView.
Objective This study aimed to determine if program format (in‐person, virtual, or hybrid) results in differences in 3‐month outcomes of pain, function, quality of life, self‐efficacy, and chair stands in a hip/knee osteoarthritis‐management program. Methods A secondary analysis of the Good Life with osteoArthritis in Denmark (GLA:D) Canada database was
Jill Van Damme, Vanina Dal Bello‐Haas, Ayse Kuspinar, Patricia Strachan, Michael Zywiel, James Young, Rhona McGlasson, Lisa C. Carlesso   +7 more
wiley   +1 more source

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

New England Journal of Medicine, 2017
B. Neal, V. Perkovic, K. Mahaffey, D. de Zeeuw, G. Fulcher, N. Erondu, Wayne Shaw, G. Law, Mehul Desai, D. Matthews   +9 more
semanticscholar   +1 more source

Organisational downsizing, sickness absence, and mortality: 10-town prospective cohort study [PDF]

, 2004
Objective To examine whether downsizing, the reduction of personnel in organisations, is a predictor of increased sickness absence and mortality among employees.Design Prospective cohort study over 7.5 years of employees grouped into categories on the ...
Ferrie, JE, Kivimaki, M, Linna, A, Pentti, J, Vahtera, J, Virtanen, M, Virtanen, P   +6 more
core  

Identifying High‐Impact Solutions to Address Racial and Ethnic Health Disparities in Lupus: A Consensus‐Based Approach

Arthritis Care &Research, EarlyView.
Objective We conducted formative research aimed at identifying solutions that address inequitable health outcomes in lupus due to adverse social determinants of health (SDoH). Methods We conducted a search for keywords, which provided insights into potential solutions and initiatives underway. An advisory panel of lupus experts iteratively reviewed the
Joy Buie, Michael P. Fisher, Kristen Backor, Hannah Tyldsley, Ashira Blazer, Candace Feldman, Andrea Knight, S. Sam Lim, Barbara Ann Polk, Ed Yelin, Edith Williams, Karen H. Costenbader   +11 more
wiley   +1 more source

Impact of non-participation bias due to psychiatric illness on mortality and cardiovascular event estimates: a Danish longitudinal population study [PDF]

Zerlina Rygner, Christina Ellervik, Mads Kirchheiner Rasmussen, Christian Torp‐Pedersen, Henrik E. Poulsen, Anders Jørgensen   +5 more
openalex   +1 more source

Short stature is associated with higher pulse wave velocity in subjects without overt cardiovascular disease

, 2020
Jeonggeun Moon, In Cheol Hwang, Seung Hwan Han   +2 more
openalex   +1 more source

Cardiovascular effects of variations in habitual levels of physical activity [PDF]

Mechanisms involved in human cardiovascular adaption to stress, particularly adaption to different levels of physical activity are determined along with quantitative noninvasive methods for evaluation of cardiovascular function during stess in normal ...
Blomqvist, C. G., Mitchell, J. H.
core   +1 more source

External Validation of Cardiovascular Risk Scores in the Southern Cone of Latin America: Which Predicts Better? [PDF]

, 2018
Introducción: La estimación inexacta del riesgo cardiovascular poblacional puede llevar a un manejo inadecuado de las intervenciones médicas preventivas, como, por ejemplo, el uso de estatinas.
Danaei, Goodarz, Gulayin, Pablo Elías, Gutierrez, Laura, Irazola, Vilma, Lanas, Fernando, Poggio, Rosana, Ponzo, Jaqueline, Rubinstein, Adolfo Luis   +7 more
core  

Perceptions About Asymptomatic Hyperuricemia and Views About Urate‐Lowering Therapy in People With Asymptomatic Hyperuricemia

Arthritis Care &Research, EarlyView.
Objective Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate‐lowering therapy in people with asymptomatic hyperuricemia. Methods Participants in a multinational study of
Nicola Dalbeth, Sarah Stewart, Gregory D. Gamble, Borislav Mihov, Lisa K. Stamp, Janine Haslett, William J. Taylor, Tony R. Merriman, Adwoa Dansoa Tabi‐Amponsah, Anne Horne, Tuhina Neogi, Tristan Pascart, Mariano Andrés, Maria‐Luisa Peral‐Garrido, Eleonora Norkuviene, Janitzia Vazquez‐Mellado, Till Uhlig, Mingshu Sun, Changgui Li, Keith J. Petrie   +19 more
wiley   +1 more source